Small benefits and a certain risk
Media representations of novel treatments for Alzheimer's disease
Bibliographic Data
| ID | 4592239 |
|---|---|
| Authors | Sudeepa Abeysinghe (0000-0001-6341-3417, University of Edinburgh), Yu Tao (0000-0002-6289-9969), Tao Yu (0000-0002-0496-7417, University of Edinburgh), Priscilla Kyei-Baffour (0000-0001-9523-8326, University of Edinburgh), Emily Adrion (0000-0001-5592-2270, University of Edinburgh) |
| Year | 2025 |
| Volume | 365 |
| Pages | 117554 |
| Publication date | 2025-01-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Social Science & Medicine (JOURNAL) |
| Journal identifiers | ISSN: 0277-9536 • E-ISSN: 1873-5347 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.socscimed.2024.117554 |
| PMID | 39637477 |
| OpenAlex | W4404734453 |
| Language | EN |
| Citations received | 1 |
| References cited | 36 |
The media is a key site for developing and communicating public understanding of Alzheimer's disease. Alzheimer's disease is a leading cause of dementia, and a condition that is prominent in public perceptions of ageing and cognitive decline. Novel disease-modifying treatments (DMTs) are the first innovation in Alzheimer's disease treatment for two decades, and have the potential to change how society thinks about Alzheimer's disease. This study investigates representation of risks and uncertainties of DMTs in articles published within the five highest circulation US newspapers between November 2020 and May 2024. This was a period of focused media attention on DMTs in the US, including reporting on Food and Drug Administration (FDA) review and approval processes and debates over public funding of these treatments through the Medicare program. The analysis finds that the media associated risks with the relative efficacy of the medications in comparison to the costs of these treatments. We further find that media representations highlight institutional challenges for the FDA in managing these uncertainties, within a situation characterized by expert contestation of the evidentiary basis for DMTs and patient hope for the promise that DMTs hold
Alzheimer's disease · Disease · Pathology · Climate Change Communication and Perception · Media Influence and Health · Medicine · Participatory Visual Research Methods · Psychology · Gerontology
The Role of Experts in the Covid-19 Pandemic and the Limits of Their Epistemic Authority in Democracy
The representation of highly pathogenic avian influenza in the Chinese media
A review of the effects of uncertainty in public science communication
The Social Amplification of Risk
Measles, Media and Memory
Brain health advice in the news
Risk, expert uncertainty, and Australian news media
Battles and breakthroughs
Are Experts (News)Worthy? Balance, Conflict, and Mass Media Coverage of Expert Consensus
Social representations of ‘social distancing’ in response to Covid-19 in the UK media
How do media, political and regulatory agendas influence one another in high risk policy issues
More than a medical condition
Ideological cultures and media discourses on scientific knowledge
Presenting Social Representations
Dichotomising dementia
The living death of Alzheimer's' versus 'Take a walk to keep dementia at bay
| Unique citing works | 1 |
|---|---|
| Citations per year | 1 |
| Citation span | 2025 - 2025 (1) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 1 |